SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001104659-12-023033
Filing Date
2012-04-02
Accepted
2012-04-02 08:22:44
Documents
6
Effectiveness Date
2012-04-02

Document Format Files

Seq Description Document Type Size
1 8-K a12-8473_18k.htm DEFA14A 39801
2 EX-10.1 a12-8473_1ex10d1.htm EX-10.1 234278
3 EX-99.1 a12-8473_1ex99d1.htm EX-99.1 45683
4 GRAPHIC g84731mmi001.gif GRAPHIC 2075
5 GRAPHIC g84731mmi002.jpg GRAPHIC 2796
6 GRAPHIC g84731mmi003.gif GRAPHIC 5356
  Complete submission text file 0001104659-12-023033.txt   335368
Mailing Address 901 GATEWAY BLVD S. SAN FRANCISCO CA 94080
Business Address 901 GATEWAY BLVD SOUTH SAN FRANCISCO CA 94080 6508086000
THERAVANCE INC (Filer) CIK: 0001080014 (see all company filings)

IRS No.: 943265960 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 000-30319 | Film No.: 12731245
SIC: 2834 Pharmaceutical Preparations